VRTX Quote, Financials, Valuation and Earnings

7 Day Trial

ALL ACCESS PASS

7
Get Started

Vertex Pharmaceuticals Price Quote

$228.08

VRTX Key Stats

Score

63
Vertex Pharmaceuticals (VRTX) is a Buy
Day range:
$227.26 - $231.11
52-week range:
$176.36 - $242.99
Dividend yield:
0%
P/E ratio:
22.17
P/S ratio:
8.35
P/B ratio:
6.08%
Volume:
2M
Average volume:
1.7M
1-year change:
-4.43%
Market cap:
$58B
Revenue:
$6.2B
EPS:
$8.33

How Much Does Vertex Pharmaceuticals Make?

  • How Much Are Vertex Pharmaceuticals's Sales Annually?
    VRTX Revenues are $6.2B
  • How Much Profit Does Vertex Pharmaceuticals's Make A Year?
    VRTX net income is $2.7B

Is Vertex Pharmaceuticals Growing As A Company?

  • What Is Vertex Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.29%
  • What Is Vertex Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.3%

Vertex Pharmaceuticals Stock Price Performance

  • Did Vertex Pharmaceuticals Stock Go Up Last Month?
    Vertex Pharmaceuticals share price went up by 4.34% last month
  • Did VRTX's Share Price Rise Over The Last Year?
    VRTX share price fell by -4.43% over the past 1 year

What Is Vertex Pharmaceuticals 52 Week High & Low?

  • What Is Vertex Pharmaceuticals’s 52-week High Share Price?
    Vertex Pharmaceuticals has traded as high as $242.99 over the past 52 weeks
  • What Is Vertex Pharmaceuticals’s 52-week Low Share Price?
    Vertex Pharmaceuticals has traded as low as $176.36 over the past 52 weeks

Vertex Pharmaceuticals Price To Free Cash Flow

  • Is Vertex Pharmaceuticals Stock Overvalued?
    Vertex Pharmaceuticals is trading at a price to free cash flow ratio of 31.02
  • Is Vertex Pharmaceuticals Stock Undervalued?
    Vertex Pharmaceuticals EV to Free Cash Flow ratio is 26.59
  • What Is Vertex Pharmaceuticals’s Price Earnings Growth Ratio?
    VRTX PEG ratio is 0.00
  • Is Vertex Pharmaceuticals Trading At A Premium To Earnings?
    Vertex Pharmaceuticals EV to EBIT ratio is 18.15

Is It Risky To Buy Vertex Pharmaceuticals?

  • How Much Debt Does Vertex Pharmaceuticals Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Vertex Pharmaceuticals Have?
    Cash and short term investments quarterly total is $7B
  • What Is Vertex Pharmaceuticals’s Book Value Per Share?
    Book value per share is 37.20

Is Vertex Pharmaceuticals Cash Flow Positive?

  • What Is VRTX Cash Flow From Operations?
    Cash flow from operations (TTM) is $2.1B
  • What Is Vertex Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.3B
  • What Is Vertex Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $36.8M

Vertex Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    VRTX return on invested capital is 24.44%
  • What Is Vertex Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 18.13%
  • What Is VRTX Return On Equity?
    ROE is a measure of profitability and is 24.44%

Vertex Pharmaceuticals Earnings Date & Stock Price

  • What Is Vertex Pharmaceuticals's Stock Price Today?
    A single share of VRTX can be purchased today for 228.08
  • What Is Vertex Pharmaceuticals’s Stock Symbol?
    Vertex Pharmaceuticals trades on the S&P500 under the ticker symbol: VRTX
  • When Is Vertex Pharmaceuticals’s Next Earnings Date?
    The next quarterly earnings date for Vertex Pharmaceuticals is scheduled on January 26, 2022
  • When Is VRTX's next ex-dividend date?
    Vertex Pharmaceuticals's next ex-dividend date is January 24, 2022
  • How To Buy Vertex Pharmaceuticals Stock?
    You can buy Vertex Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Vertex Pharmaceuticals Competitors

  • Who Are Vertex Pharmaceuticals's Competitors?
    Below is a list of companies who compete with Vertex Pharmaceuticals or are related in some way:
    • AbbVie Inc (ABBV)
    • Amgen Inc (AMGN)
    • Moderna Inc (MRNA)
    • Pfizer Inc (PFE)
    • Regeneron Pharmaceuticals Inc (REGN)

Vertex Pharmaceuticals Dividend Yield

Data Unavailable

Vertex Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS
29.64% 16.31%
Revenue
28.99% 6.43%

Analyst Recommendations

Buy Recommendations:
13
Hold Recommendations:
6
Sell Recommendations:
1
Price Target:
266.96
Upside from Last Price:
17.05%

Major Shareholders

  • How many VRTX shares are owned by institutional investors?
    386.4M VRTX shares are owned by institutional investors
  • How many VRTX shares are owned by insiders?
    2.4M VRTX shares are owned by insiders